Residual left atrial v wave predicts clinical outcome of transcatheter edge-to-edge mitral valve repair [0.03%]
房颤患者经导管二尖瓣修复术后残留左心耳v波的临床意义
Michael Paulus,Jonas Rösch,Franziska Grewe et al.
Michael Paulus et al.
Background and aims: Intraprocedural assessment of residual mitral regurgitation (MR) is crucial for the success of transcatheter edge-to-edge mitral valve repair (M-TEER), yet challenging in the case of ambiguous echocar...
Observational Study
ESC heart failure. 2026 Mar 3;13(2):xvag086. DOI:10.1093/eschf/xvag086 2026
Addressing the gaps in heart failure treatment for frail older adults: challenges, evidence, and future directions [0.03%]
针对虚弱老年人心力衰竭治疗不足的应对策略：挑战、证据和未来方向
Marius Myrstad,Elisabeth Skaar,Peder Langeland Myhre
Marius Myrstad
Real-world evidence with dapagliflozin in heart failure with reduced ejection fraction in Central Eastern Europe and the Baltic region (EVOLUTION-HF CEE-BA Study) [0.03%]
达格列净在中欧东欧和波罗的海地区射血分数降低的心力衰竭患者中的真实世界证据（EVOLUTION-HF CEE-BA研究）
Przemysław Leszek,Zoltan Csanádi,Ivan Gruev et al.
Przemysław Leszek et al.
Aims: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are currently recommended as one of the four pillars of treatment in heart failure (HF) with reduced ejection fraction (HFrEF). Following the approval of dapagliflo...
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter Study [0.03%]
依那普利拉/缬沙坦治疗慢性HFrEF长期预后的意大利真实世界多中心研究
Giuseppe Dattilo,Roberto Licordari,Egidio Imbalzano et al.
Giuseppe Dattilo et al.
Background and aims: Long-term real-world effects of sacubitril/valsartan (S/V) and the impact of S/V dose reduction or discontinuation are less defined. We assessed longitudinal changes after S/V initiation and the assoc...
Left Ventricular Reverse Remodeling after Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPANDed Studies [0.03%]
经导管二尖瓣缘对缘修复后的左心室反向重塑：来自EXPANDED研究的结果
Mirjam Keßler,Gilbert H L Tang,Sébastien Deferm et al.
Mirjam Keßler et al.
Background: Left ventricular reverse remodeling (LVRR) is a key objective of contemporary heart failure (HF) therapies and is characterized by reversal of left ventricular (LV) dilation and dysfunction. ...
Cardiac Biomarkers Response Under Angiotensin Receptor-Neprilysin Inhibitor: A Sub-Analysis of the Natrium-HF Study [0.03%]
基于钠研究的亚组分析：血管紧张素受体-中性肽酶抑制剂对心脏生物标志物反应的影响
Jolie Bruno,Aziz Daghmouri,Malha Sadoune et al.
Jolie Bruno et al.
Aims: Natriuretic peptides (NPs) are central to the diagnostic and therapeutic management of heart failure (HF), yet their short-term dynamics under sacubitril/valsartan (S/V) therapy and during acute volume changes remai...
cDPP3 and Outcomes in Acute Heart Failure: An Analysis of the STRONG-HF and CORTAHF Studies [0.03%]
急性心力衰竭患者B型利钠肽前体C末端片段与预后关系的STRONG-HF和CORT-AHF研究亚组分析
J Bruno,C Edwards,K Takagi et al.
J Bruno et al.
Aims: Circulating dipeptidyl peptidase 3 (cDPP3) is implicated in cardiocirculatory failure and elevated concentrations predict poor outcomes in shock states. Its role in acute heart failure (AHF) is unexplored. We assess...
Kidney tubule injury is associated with sodium avidity and diuretic responsiveness in acute heart failure [0.03%]
急性心力衰竭患者的肾小管损伤与钠亲和力及利尿剂反应性降低有关联
Yu Horiuchi,Stephen Duff,Dirk J van Veldhuisen et al.
Yu Horiuchi et al.
Aims: Greater sodium avidity in acute heart failure (AHF) is associated with worse outcomes, but whether kidney tubule injury is associated with sodium avidity and impaired diuretic responsiveness remains underexplored. ...
Small Left Ventricular Volume in HFpEF: From Phenotype to Clinical Implications [0.03%]
射血分数保留的心力衰竭中左心室容积偏小：从表型到临床意义
Julio Núñez,Jan Verwerft,Gema Miñana et al.
Julio Núñez et al.
Envisioning the Next Steps for Machine Learning Models in Integrated Cardiovascular-Kidney-Metabolic Care [0.03%]
集成心血管-肾脏-代谢护理中机器学习模型的下一步展望
Wenze Kan,Mengqi Zhou,Peng Xu
Wenze Kan